It introduced a prognostic staging system, which incorporates tumour grade, hormone receptors (oestrogen receptor [ER], and progesterone receptor [PR]) and oncogene status (HER2), further modified to include multigene panel results in a subset of patients to amend the anatomical stage.16 The gene discussed is PGR; the disease is neoplasm.